{"id":48801,"date":"2022-09-07T17:25:46","date_gmt":"2022-09-07T15:25:46","guid":{"rendered":"https:\/\/www.aiom.it\/?p=48801"},"modified":"2022-09-07T17:25:46","modified_gmt":"2022-09-07T15:25:46","slug":"pembrolizumab-plus-chemotherapy-in-advanced-triple-negative-breast-cancer","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/pembrolizumab-plus-chemotherapy-in-advanced-triple-negative-breast-cancer\/","title":{"rendered":"Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p><em>Javier Cortes, Hope S Rugo, David W Cescon, Seock-Ah Im, Mastura M Yusof, Carlos Gallardo, Oleg Lipatov, Carlos H Barrios, Jose Perez-Garcia, Hiroji Iwata, Norikazu Masuda, Marco Torregroza Otero, Erhan Gokmen, Sherene Loi, Zifang Guo, Xuan Zhou, Vassiliki Karantza, Wilbur Pan, Peter Schmid, KEYNOTE-355 Investigators <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-28246\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-221x300.jpg\" alt=\"\" width=\"221\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-221x300.jpg 221w, https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-768x1041.jpg 768w, https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-756x1024.jpg 756w, https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-810x1098.jpg 810w, https:\/\/www.aiom.it\/wp-content\/uploads\/2018\/12\/NEJM_cover-1140x1545.jpg 1140w\" sizes=\"auto, (max-width: 221px) 100vw, 221px\" \/><\/em><\/p>\n<p><em>The New England Journal of Medicine<\/em>, 2022 Jul. 21<\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35857659\/\">Abstract link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Copyright \u00a9 2022 Massachusetts Medical Society.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Javier Cortes, Hope S Rugo, David W Cescon, Seock-Ah Im, Mastura M Yusof, Carlos Gallardo, Oleg Lipatov, Carlos H Barrios, Jose Perez-Garcia, Hiroji Iwata, Norikazu Masuda, Marco Torregroza Otero, Erhan Gokmen, Sherene Loi, Zifang Guo, Xuan Zhou, Vassiliki Karantza, Wilbur Pan, Peter Schmid, KEYNOTE-355 Investigators The New England Journal of Medicine, 2022 Jul. 21 [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":33043,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[],"class_list":["post-48801","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/48801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=48801"}],"version-history":[{"count":2,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/48801\/revisions"}],"predecessor-version":[{"id":48803,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/48801\/revisions\/48803"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/33043"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=48801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=48801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=48801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}